top bar
enough to make the interference due to endogenous PG insignificant. It should also be noted that the purified glypican-AP contains HS chains of varying length and degree of sulfation so that the Kd obtained represents an average value of a population of glypican molecules with the same core protein, but with different glycanation patterns.
Among the ligands examined, bFGF yields the highest binding affinity against glypican, which is consistent with previous findings that HSPGs are necessary for receptor binding and mitogenic activity of bFGF (Aviezer et al. 1994). The affinities determined for the binding between 293-derived glypican and collagen are similar to those obtained for the binding of low-molecular weight heparin (Kd =315±83 nM) and syndecan (derived from normal murine mammary gland epithelial cells, Kd = 164±7 nM) against the same ligand (San Antonio et al. 1993). Glypican, syndecan, and heparin share a common structural feature, namely the presence of sulfated polysaccharides; the similarity in the binding affinities thus suggests that glypican may have a similar collagen-binding determinant as heparin or syndecan within the sugar chains. The Kd value obtained for laminin-1, on the other hand, is substantially lower than that obtained for the binding between laminin-1 and glypican (obtained in the rat brain; Herndon and Lander 1992). Brain-derived glypican tends to have longer, more heavily sulfated HS chains, suggesting that 1) glypican's binding affinity against laminin-1 depends primarily on its GAG chains rather than its core protein and 2) that the nature of the GAG chains (for example, their length and degree of sulfation) is more important for binding against laminin than against bFGF.
Binding heterogeneity in the interaction of glypican and its ligands­as shown by highly extended bands on the ACE electrophoretograms­is lower for bFGF than for collagen (and possibly laminin). Further, the low R¥ values for collagen strongly suggest the presence of a glypican subpopulation in the PG sample that does not bind collagen. Yet no such subpopulation is seen with bFGF. Apparently, there exists a glypican subpopulation that 1) does not bind, or binds very weakly to, collagen and 2) binds bFGF with moderate to high affinities. Comparison of Kd values obtained for the binding of glypican-AP from 293 and CHO cells against the three ligands shows that glypican from the two cell lines binds bFGF or laminin-1 with similar affinities, yet binds collagen with significantly different affinities (Figure 7).